These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9295869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L, Loriot MA.
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [Abstract] [Full Text] [Related]

  • 4. Cytochrome P450 pharmacogenetics and cancer.
    Rodriguez-Antona C, Ingelman-Sundberg M.
    Oncogene; 2006 Mar 13; 25(11):1679-91. PubMed ID: 16550168
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacogenetics and its importance in the clinical].
    Lares-Asseff I, Trujillo-Jiménez F.
    Gac Med Mex; 2001 Mar 13; 137(3):227-36. PubMed ID: 11432091
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicity.
    Boddy AV, Idle JR.
    Cancer Surv; 1993 Mar 13; 17():79-104. PubMed ID: 8137354
    [Abstract] [Full Text] [Related]

  • 10. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW, McLeod HL.
    Curr Opin Mol Ther; 2002 Dec 13; 4(6):565-71. PubMed ID: 12596358
    [Abstract] [Full Text] [Related]

  • 11. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
    Robaey P, Krajinovic M, Marcoux S, Moghrabi A.
    Dev Disabil Res Rev; 2008 Dec 13; 14(3):211-20. PubMed ID: 18924160
    [Abstract] [Full Text] [Related]

  • 12. Current overview of pharmacogenetics.
    McLeod HL.
    Clin Adv Hematol Oncol; 2004 Apr 13; 2(4):205-7. PubMed ID: 16163181
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cancer pharmacogenomics: international trends.
    Yamayoshi Y, Iida E, Tanigawara Y.
    Int J Clin Oncol; 2005 Feb 13; 10(1):5-13. PubMed ID: 15729594
    [Abstract] [Full Text] [Related]

  • 15. [Genomic markers and anticancer chemotherapy].
    Nishiyama M.
    Gan To Kagaku Ryoho; 2008 Feb 13; 35(2):194-9. PubMed ID: 18281756
    [Abstract] [Full Text] [Related]

  • 16. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
    Mladosievicova B, Carter A, Kristova V.
    Neoplasma; 2007 Feb 13; 54(3):181-8. PubMed ID: 17447847
    [Abstract] [Full Text] [Related]

  • 17. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
    Lee W, Lockhart AC, Kim RB, Rothenberg ML.
    Oncologist; 2005 Feb 13; 10(2):104-11. PubMed ID: 15709212
    [Abstract] [Full Text] [Related]

  • 18. Pharmacogenetics in cancer treatment.
    Nagasubramanian R, Innocenti F, Ratain MJ.
    Annu Rev Med; 2003 Feb 13; 54():437-52. PubMed ID: 12525681
    [Abstract] [Full Text] [Related]

  • 19. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
    Ozawa S.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999 Feb 13; (117):63-76. PubMed ID: 10859937
    [Abstract] [Full Text] [Related]

  • 20. [Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].
    Nishiyama M.
    Gan To Kagaku Ryoho; 2005 Nov 13; 32(12):1902-7. PubMed ID: 16282724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.